Aclaris Therapeutics
Price & Volume
Stats
See more52W Range | $0.95-$5.17 |
Market Cap | $147.2M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $18.7M |
Revenue Growth (YoY) | -47.6% |
Gross Profit (12 Mos) | -$30.3M |
Diluted EPS | -$1.71 |
News
See moreYahoo Finance • 8 days ago
Aclaris Therapeutics Secures U.S. Food and Drug Administration IND Clearance for ATI-052, Enabling Advancement of its Novel Bispecific Anti-TSLP/IL-4R Investigational Antibody
Yahoo Finance • 2 months ago
Aclaris Therapeutics to Participate in Two March Healthcare Conferences
Yahoo Finance • 3 months ago
New Publication Highlights Unique Properties of ATI-2138, a Potent and Selective Inhibitor of ITK and JAK3
Yahoo Finance • 3 months ago
Aclaris Therapeutics Announces Formation of New Scientific Advisory Board
About
CEO | Dr. Neal S. Walker D.O., M.D. |
Address | 701 Lee Road, Wayne, PA, United States, 19087 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Full-Time Employees | 61 |
